- Home
- HNNA vs ADAG Comparison
HNNA vs ADAG Comparison
Compare HNNA & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNNA
- ADAG
- Stock Information
- Founded
- HNNA 1989
- ADAG 2011
- Country
- HNNA United States
- ADAG China
- Employees
- HNNA N/A
- ADAG N/A
- Industry
- HNNA Investment Managers
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- HNNA Finance
- ADAG Health Care
- Exchange
- HNNA Nasdaq
- ADAG Nasdaq
- Market Cap
- HNNA 82.4M
- ADAG 81.9M
- IPO Year
- HNNA N/A
- ADAG 2021
- Fundamental
- Price
- HNNA $9.84
- ADAG $1.54
- Analyst Decision
- HNNA
- ADAG Strong Buy
- Analyst Count
- HNNA 0
- ADAG 1
- Target Price
- HNNA N/A
- ADAG $8.00
- AVG Volume (30 Days)
- HNNA 14.5K
- ADAG 44.8K
- Earning Date
- HNNA 05-07-2025
- ADAG 03-24-2025
- Dividend Yield
- HNNA 5.52%
- ADAG N/A
- EPS Growth
- HNNA 75.66
- ADAG N/A
- EPS
- HNNA 1.12
- ADAG N/A
- Revenue
- HNNA $33,210,000.00
- ADAG $103,204.00
- Revenue This Year
- HNNA N/A
- ADAG $6,488.89
- Revenue Next Year
- HNNA N/A
- ADAG $57.50
- P/E Ratio
- HNNA $9.08
- ADAG N/A
- Revenue Growth
- HNNA 38.27
- ADAG N/A
- 52 Week Low
- HNNA $6.60
- ADAG $1.33
- 52 Week High
- HNNA $13.88
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- HNNA 31.70
- ADAG 42.87
- Support Level
- HNNA $9.61
- ADAG $1.33
- Resistance Level
- HNNA $10.73
- ADAG $1.87
- Average True Range (ATR)
- HNNA 0.32
- ADAG 0.19
- MACD
- HNNA -0.01
- ADAG -0.01
- Stochastic Oscillator
- HNNA 12.60
- ADAG 49.45
About HNNA Hennessy Advisors Inc.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.